These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22143817)

  • 1. 23-valent pneumococcal vaccine failure in a patient who developed pneumonia: a case report.
    Tafuri S; Martinelli D; Grimaldi A; Lopatriello A; Giorgio V; Prato R
    New Microbiol; 2011 Oct; 34(4):417-20. PubMed ID: 22143817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly.
    Ortqvist A; Henckaerts I; Hedlund J; Poolman J
    Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease.
    Principi N; Esposito S
    Expert Rev Vaccines; 2015; 14(10):1359-66. PubMed ID: 26289973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
    Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ
    Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [23-valent pneumococcal vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society: February 2010].
    Ripoll M E; Valenzuela B MT; Vergara F R; Abarca V K; Muñoz M A; Jiménez de la Jara J; Pinto C ME; Luchsinger F V
    Rev Chilena Infectol; 2010 Apr; 27(2):133-7. PubMed ID: 20556313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
    Diawara I; Zerouali K; Elmdaghri N; Abid A
    BMC Pediatr; 2017 Apr; 17(1):114. PubMed ID: 28449653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.
    Suzuki M; Dhoubhadel BG; Ishifuji T; Yasunami M; Yaegashi M; Asoh N; Ishida M; Hamaguchi S; Aoshima M; Ariyoshi K; Morimoto K;
    Lancet Infect Dis; 2017 Mar; 17(3):313-321. PubMed ID: 28126327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines.
    Chuck AW; Jacobs P; Tyrrell G; Kellner JD
    Vaccine; 2010 Jul; 28(33):5485-90. PubMed ID: 20554066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of community-acquired pneumonia in adults].
    Barros M M; Cartagena S C; Bavestrello F L
    Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar].
    Isapof A; Delacourt C; Reinert P; Cohen R; Madhi F
    Arch Pediatr; 2009 Aug; 16(8):1133-6. PubMed ID: 19500954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of 7-valent pneumococcal conjugate vaccine.
    Ghaffar F
    Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness.
    Iroh Tam PY; Hanisch BR; Forward B
    Clin Pediatr (Phila); 2015 Jun; 54(6):591-3. PubMed ID: 25500500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine.
    Antachopoulos C; Tsolia MN; Tzanakaki G; Xirogianni A; Dedousi O; Markou G; Zografou SM; Eliades A; Kirvassilis F; Kesanopoulos K; Roilides E
    Pediatr Infect Dis J; 2014 Jan; 33(1):81-3. PubMed ID: 24172850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine.
    Salleras L; Domínguez A; Ciruela P; Izquierdo C; Navas E; Torner N; Borras E
    Clin Microbiol Infect; 2009 Nov; 15(11):997-1001. PubMed ID: 19689466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
    Oosterhuis-Kafeja F; Beutels P; Van Damme P
    Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.